Disentangling on and off-target binding in flortaucipir PET: a voxel-to-voxel P-tau, ferric iron, and MAO-B histology-to-flortaucipir PET comparison
Flortaucipir PET imaging has significantly advanced our ability to visualize tau pathology in vivo. However, off-target Flortaucipir signal remains a considerable challenge for interpreting of imaging results, particularly in non-Alzheimer's tauopathies and non-tau pathologies. To better understand this off-target signal, we used an innovative voxel-to-voxel correlation approach, analyzing thousands of histology-Flortaucipir pairs from individual cases. This allowed us to quantitatively assess the relationship between Flortaucipir PET signal and three key biological factors: histological tau burden (CP-13 phospho-tau), ferric iron (Perls' Prussian blue), and monoamine oxidase B (MAO-B). Our study included individuals with Alzheimer's disease (AD), various non-AD tauopathies, and a case of FTLD-TDP-43 type A. In AD, Flortaucipir signal showed a significant but moderate correlation with histological tau pathology, suggesting that while tau is a major contributor, other biological factors also influence Flortaucipir binding in AD. Conversely, in non-AD tauopathies and FTLD-TDP-43, correlations between Flortaucipir signal and tau pathology were weak or negligible. Instead, Flortaucipir signal correlated more strongly with ferric iron and MAO-B. However, these factors did not fully explain all the off-target signals, implying other unknown contributors are likely involved. These findings underscore the complexity of interpreting Flortaucipir PET scans. A thorough understanding of off-target binding mechanisms is crucial for improving the diagnostic accuracy of Flortaucipir PET and its specificity.
Authors
- Ganna Blazhenets (ORCID: https://orcid.org/0000-0003-2419-7373)
- Y. Chen
- Lucile Zhu
- William W. Seeley
- Renaud La Joie
- Daniela Ushizima
- Duygu Tosun
- Lea T. Grinberg
- Helmut Heinsen
- Gil D. Rabinovici
- Salvatore Spina
- Felipe L. Pereira
Institutions
- Lawrence Berkeley National Laboratory (US)
- University of California, San Francisco (US)
- University of Würzburg (DE)
- Jacksonville College (US)
- University Memory and Aging Center (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Acta Neuropathologica
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1007/s00401-026-02983-x
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- National Institute on Aging